CytomX Therapeutics, Inc. CTMX
Set alert
2.23 USD -0.11 -4.70%
At close · Nov 2
2.23 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
2.14 Day range 2.39
2.22 52-week range 6.75
- YTD
- -47.65%
- 1 year
- -37.54%
- Open
- 2.36
- Prev close
- 2.34
- Mkt cap
- 485.92M
- Vol
- 9.47M
- Avg vol
- 3.50M
- EPS
- -0.49
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.14
- High
- 2.39
- Forward P/E
- -9.74
- Beta
- 2.48
- Short ratio
- 1.78
- Inst. own
- 75.69%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.92
- 200-d avg
- 3.77
- 1y target
- 13.67
5D chart
Signals (59)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Nov 2, 3:35 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 3:30 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 3:00 PM | 12 hours ago |
| MACD: Buy Signal | Nov 2, 2:55 PM | 12 hours ago |
| RSI: Oversold | Nov 2, 1:45 PM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 1:30 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 12:10 PM | 15 hours ago |
| SMA: Bullish | Nov 2, 12:05 PM | 15 hours ago |
| MACD: Buy Signal | Nov 2, 11:35 AM | 15 hours ago |
| SMA: Bearish | Nov 2, 10:30 AM | 17 hours ago |
| SMA: Bearish | Nov 2, 10:30 AM | 17 hours ago |
| SMA: Bullish | Nov 2, 10:20 AM | 17 hours ago |
| SMA: Bullish | Nov 2, 10:20 AM | 17 hours ago |
| SMA: Bearish | Nov 2, 10:15 AM | 17 hours ago |
| SMA: Bearish | Nov 2, 9:45 AM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 9:45 AM | 17 hours ago |
| RSI: Overbought | Oct 30, 3:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:50 PM | 3 days ago |
Newest 20 of 59.
Financial health
Altman Z-Score
1.38 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -28.4×
FY 2016 5y median -3.4× FY 2025
P/S 7.7×
FY 2016 5y median 2.0× FY 2025
P/B 5.9×
FY 2016 5y median -2.4× FY 2025
P/FCF -7.8×
FY 2016 5y median -2.0× FY 2025
EV/EBITDA -36.8×
FY 2016 5y median 0.7× FY 2025
EV/Sales 7.6×
FY 2016 5y median 1.1× FY 2025
FCF Yield -12.9%
FY 2016 5y median -49.7% FY 2025
Profitability
Gross Margin 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -29.3%
FY 2016 5y median -29.3% FY 2025
Net Margin -22.8%
FY 2016 5y median -22.8% FY 2025
ROE -17.5%
FY 2016 5y median 1.2% FY 2025
ROIC -20.5%
FY 2016 5y median -20.5% FY 2025
ROA -11.5%
FY 2016 5y median -11.5% FY 2025
Growth (YoY)
Revenue -44.8%
FY 2016 FY 2025
Operating Income -189.5%
FY 2016 FY 2025
EPS (diluted) -139.5%
FY 2016 FY 2025
Free Cash Flow 12.4%
FY 2016 FY 2025
Financial Health
Current Ratio 3.1×
FY 2016 5y median 1.6× FY 2025
Quick Ratio 3.1×
FY 2016 5y median 1.6× FY 2025
Debt / Equity 0.0×
FY 2016 5y median -0.3× FY 2025
Net Debt / EBITDA 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
